# Viet Nam Export Playbook for Europe

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks regional export playbook

Compare buyer markets, access conditions, and calculated product opportunities in Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.

## Navigation

- [Yugalinks home](https://www.yugalinks.com/)
- [Trade data](https://www.yugalinks.com/trade/)
- [Open country workspace](https://www.yugalinks.com/app/countries)
- [Data sources](https://www.yugalinks.com/data-sources)
- [Methodology](https://www.yugalinks.com/methodology)

## Overview

- Exporter: Viet Nam (VNM)
- Region: Europe
- Latest trade year: 2024
- Buyer markets: 23
- Calculated three-year opportunity: $713.8B
- Reported FTA markets: 18
- Average reported distance: 8,116 km
- Average business entry indicator: 11 days

## Market comparison

| Market | ISO3 | Opportunity | Products | FTA | Distance | Entry days | Top product |
| --- | --- | ---: | ---: | --- | ---: | ---: | --- |
| Germany | DEU | $153.9B | 55 | Reported | 8,793 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United Kingdom | GBR | $107.1B | 24 | Reported | 9,249 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| Netherlands | NLD | $96.5B | 24 | Reported | 8,892 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, Liechtenstein | CHE | $81.3B | 10 | Not reported | 8,936 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| France | FRA | $67.6B | 24 | Reported | 9,209 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Belgium | BEL | $59.0B | 10 | Reported | 8,990 km | 5 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Spain | ESP | $19.2B | 8 | Reported | 10,053 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| Poland | POL | $18.5B | 11 | Reported | 7,841 km | 37 | Telephones for cellular networks or for other wireless networks |
| Czechia | CZE | $17.5B | 8 | Reported | 8,339 km | 25 | Telephones for cellular networks or for other wireless networks |
| Italy | ITA | $16.1B | 7 | Reported | 8,742 km | 11 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| Russia | RUS | $15.6B | 9 | Not reported | 6,738 km | 10 | Telephones for cellular networks or for other wireless networks |
| Slovenia | SVN | $14.2B | 3 | Reported | 8,453 km | 8 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| Ireland | IRL | $8.5B | 3 | Reported | 9,520 km | 11 | Electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits |
| Greece | GRC | $8.1B | 3 | Reported | 7,930 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Austria | AUT | $7.4B | 4 | Reported | 8,255 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| Malta | MLT | $5.8B | 2 | Reported | 8,780 km | 21 | Vessels: n.e.s. in heading no. 8901, for the transport of goods and other vessels for the transport of both persons and goods |
| Sweden | SWE | $5.1B | 3 | Reported | 7,893 km | 8 | Vehicles: with only electric motor for propulsion |
| Hungary | HUN | $2.9B | 2 | Reported | 8,078 km | 7 | Telephones for cellular networks or for other wireless networks |
| Slovakia | SVK | $2.7B | 2 | Reported | 8,198 km | 22 | Vehicles: parts and accessories, of bodies, other than safety seat belts |
| Denmark | DNK | $2.4B | 2 | Reported | 8,300 km | 4 | Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale |
| Norway | NOR | $1.5B | 1 | Not reported | 8,283 km | 4 | Product not reported |
| Ukraine | UKR | $1.4B | 1 | Not reported | 7,206 km | 7 | Product not reported |
| Romania | ROU | $1.2B | 1 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |

## Product and market opportunities

| Rank | Market | Product | Opportunity | Buyer growth | Current share |
| ---: | --- | --- | ---: | ---: | ---: |
| 1 | Switzerland, Liechtenstein (CHE) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | United Kingdom (GBR) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $26.2B | +15.3% | +0.0% |
| 3 | Belgium (BEL) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $20.7B | +7.6% | +0.0% |
| 4 | Germany (DEU) | HS 850760 - Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.1% |
| 5 | Netherlands (NLD) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 6 | Switzerland, Liechtenstein (CHE) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $17.3B | +12.8% | +0.0% |
| 7 | Switzerland, Liechtenstein (CHE) | HS 710813 - Metals: gold, semi-manufactured | $17.2B | +14.3% | +0.0% |
| 8 | United Kingdom (GBR) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.4B | +5.5% | +0.0% |
| 9 | Belgium (BEL) | HS 271019 - Product description unavailable | $12.8B | +9.1% | +0.0% |
| 10 | Germany (DEU) | HS 271019 - Product description unavailable | $12.3B | +5.8% | +0.0% |
| 11 | Netherlands (NLD) | HS 271019 - Product description unavailable | $11.9B | +12.2% | +0.0% |
| 12 | United Kingdom (GBR) | HS 870380 - Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 13 | Slovenia (SVN) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 14 | Belgium (BEL) | HS 300220 - Vaccines: for human medicine | $8.0B | +20.4% | +0.0% |
| 15 | Germany (DEU) | HS 847130 - Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.0B | +3.5% | +4.0% |
| 16 | Germany (DEU) | HS 851712 - Telephones for cellular networks or for other wireless networks | $7.8B | +9.2% | +10.4% |
| 17 | Netherlands (NLD) | HS 847130 - Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $7.1B | +4.0% | +1.9% |
| 18 | Belgium (BEL) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | +8.9% | +0.0% |
| 19 | France (FRA) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $6.3B | +3.8% | +0.1% |
| 20 | France (FRA) | HS 870380 - Vehicles: with only electric motor for propulsion | $6.2B | +31.1% | +0.0% |

## Sector opportunities

| Sector | Products | Reported buyer imports | Opportunity | Average growth |
| --- | ---: | ---: | ---: | ---: |
| HS2 30 - HS2 sector 30 | 30 | $269.5B | $126.6B | +10.9% |
| HS2 85 - HS2 sector 85 | 46 | $221.0B | $124.6B | +12.1% |
| HS2 71 - HS2 sector 71 | 11 | $214.7B | $80.6B | +11.5% |
| HS2 00 - HS2 sector 00 | 20 | $192.4B | $79.4B | +8.2% |
| HS2 27 - HS2 sector 27 | 10 | $155.4B | $76.8B | +12.0% |
| HS2 84 - HS2 sector 84 | 24 | $110.7B | $69.6B | +7.6% |
| HS2 87 - HS2 sector 87 | 25 | $125.2B | $56.7B | +15.7% |
| HS2 88 - HS2 sector 88 | 5 | $35.0B | $16.9B | +7.9% |

## Frequently asked questions

### Should Viet Nam focus on Europe?

Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.

### What does calculated opportunity mean?

It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.

### How should exporters use this page?

Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, tariffs, standards, logistics, pricing, and competition before acting.

Yugalinks presents derived views for research and planning. [Read the full methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.